Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

This study has been completed.
Sponsor:
Information provided by:
Adnexus, A Bristol-Myers Squibb R&D Company
ClinicalTrials.gov Identifier:
NCT00374179
First received: September 8, 2006
Last updated: February 23, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
No publications provided by Adnexus, A Bristol-Myers Squibb R&D Company

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):